I am a
Home I AM A Search Login

Papers of the Week

Papers: 4 Jan 2020 - 10 Jan 2020

Human Studies, Pharmacology/Drug Development

2020 03 01

Pain Med



High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.


Jann S, Fazio R, Cocito D, Toscano A, Schenone A, Marfia G A, Antonini G, De Toni Franceschini L, Mazzeo A, Grandis M, Velardo D, Mataluni G, Peci E
Pain Med. 2020 03 01; 21(3):576-585.
PMID: 31904855.


The efficacy and safety of high-dose intravenous immunoglobulin (IVIG) in treatment-resistant diabetic painful polyneuropathy (DPN) were assessed.